PTC Therapeutics (PTCT) had the highest return in January 2014 by a mid-cap US stock, returning 55.8%.
| ASSET | MONTH | % RETURN |
|---|---|---|
PTC Therapeutics (PTCT) | January 2014 | 55.83% |
TG Therapeutics (TGTX) | January 2014 | 51.52% |
Travere Therapeutics (TVTX) | January 2014 | 47.15% |
Plug Power (PLUG) | January 2014 | 46.6% |
MakeMyTrip (MMYT) | January 2014 | 43.41% |
Arrowhead Pharmaceuticals (ARWR) | January 2014 | 42.7% |
Danaos (DAC) | January 2014 | 42.36% |
Precigen (PGEN) | January 2014 | 41.95% |
Energy Fuels (UUUU) | January 2014 | 36.74% |
BioCryst Pharmaceuticals (BCRX) | January 2014 | 35.1% |
American Airlines (AAL) | January 2014 | 33.83% |
Supernus Pharmaceuticals (SUPN) | January 2014 | 30.09% |
Ionis Pharmaceuticals (IONS) | January 2014 | 28.32% |
Skyline (SKY) | January 2014 | 28.21% |
Vipshop (VIPS) | January 2014 | 27.2% |
BlackBerry (BB) | January 2014 | 26.85% |
JOYY (JOYY) | January 2014 | 26.6% |
Enpro Industries (NPO) | January 2014 | 25.81% |
Qualys (QLYS) | January 2014 | 25.45% |
Perpetua Resources (PPTA) | January 2014 | 24.81% |
Camtek (CAMT) | January 2014 | 24.64% |
Patrick Industries (PATK) | January 2014 | 24.52% |
Under Armour Inc A (UAA) | January 2014 | 23.84% |
Fortuna Silver Mines (FSM) | January 2014 | 22.71% |
Alkermes (ALKS) | January 2014 | 20.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.